378 related articles for article (PubMed ID: 20405054)
1. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial.
Debrah AY; Specht S; Klarmann-Schulz U; Batsa L; Mand S; Marfo-Debrekyei Y; Fimmers R; Dubben B; Kwarteng A; Osei-Atweneboana M; Boakye D; Ricchiuto A; Büttner M; Adjei O; Mackenzie CD; Hoerauf A
Clin Infect Dis; 2015 Aug; 61(4):517-26. PubMed ID: 25948064
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
4. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
5. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
6. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.
Hoerauf A; Specht S; Büttner M; Pfarr K; Mand S; Fimmers R; Marfo-Debrekyei Y; Konadu P; Debrah AY; Bandi C; Brattig N; Albers A; Larbi J; Batsa L; Taylor MJ; Adjei O; Büttner DW
Med Microbiol Immunol; 2008 Sep; 197(3):295-311. PubMed ID: 17999080
[TBL] [Abstract][Full Text] [Related]
7. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
8. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
Pion SD; Clarke P; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jun; 132(Pt 6):843-54. PubMed ID: 16469200
[TBL] [Abstract][Full Text] [Related]
9. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
10. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.
Hoerauf A; Mand S; Adjei O; Fleischer B; Büttner DW
Lancet; 2001 May; 357(9266):1415-6. PubMed ID: 11356444
[TBL] [Abstract][Full Text] [Related]
11. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.
Hoerauf A; Specht S; Marfo-Debrekyei Y; Büttner M; Debrah AY; Mand S; Batsa L; Brattig N; Konadu P; Bandi C; Fimmers R; Adjei O; Büttner DW
Parasitol Res; 2009 Jan; 104(2):437-47. PubMed ID: 18850111
[TBL] [Abstract][Full Text] [Related]
13. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
[TBL] [Abstract][Full Text] [Related]
14. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
[TBL] [Abstract][Full Text] [Related]
15. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Pion SD; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jul; 133(Pt 1):101-9. PubMed ID: 16764737
[TBL] [Abstract][Full Text] [Related]
16. Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis.
Tamarozzi F; Tendongfor N; Enyong PA; Esum M; Faragher B; Wanji S; Taylor MJ
Parasit Vectors; 2012 Mar; 5():53. PubMed ID: 22433114
[TBL] [Abstract][Full Text] [Related]
17. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
18. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
19. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.
Wanji S; Tendongfor N; Nji T; Esum M; Che JN; Nkwescheu A; Alassa F; Kamnang G; Enyong PA; Taylor MJ; Hoerauf A; Taylor DW
Parasit Vectors; 2009 Aug; 2(1):39. PubMed ID: 19712455
[TBL] [Abstract][Full Text] [Related]
20. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
